John P. Mallamo

Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery

Arup K. Ghose, Torsten Herbertz, Robert L. Hudkins et al. · ACS Chemical Neuroscience · 2011 · 432 citations · Full text

Cns Drug Discovery, Pharmaceutical Research, Drug Target +18

Discovery of a Potent, Selective, and Orally Active Proteasome Inhibitor for the Treatment of Cancer

Bruce D. Dorsey, Mohamed Iqbal, Sankar Chatterjee et al. · Journal of Medicinal Chemistry · 2008 · 146 citations · Full text

High asymmetric induction during organometallic .beta.-addition to .alpha.,.beta.-ethylenic sulfoxides. Synthesis of optically active .beta.-alkylcarboxylic acids, .beta.-substituted cyclopentanones, and steroidal 11-oxoequilenin methyl ether

Gary H. Posner, John P. Mallamo, Kyo Miura · Journal of the American Chemical Society · 1981 · 129 citations

Enantioselective Synthesis, Organometallic .Beta.-addition, Donut Icon +10

Neurotrophic 3,9-Bis[(alkylthio)methyl]- and -Bis(alkoxymethyl)-K-252a Derivatives

Masami Kaneko, Yutaka Saito, Hiromitsu Saito et al. · Journal of Medicinal Chemistry · 1997 · 119 citations · Full text

Structure-guided identification of novel VEGFR-2 kinase inhibitors via solution phase parallel synthesis

Rabindranath Tripathy, Alyssa Reiboldt, Patricia A. Messina et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 104 citations · Full text

Medicinal Chemistry, Drug Target, Medicine +9